AARON SWISHER: Open Payments
NPI 1255331609 · HILDEBRAN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 90 payments from 22 companies in 2025. Trend: 2023 $1,845 · 2024 $1,875 · 2025 $1,901
Food & beverage: $1,901
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $579 |
| PFIZER INC. | 9 | $172 |
| ABBVIE INC. | 10 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $137 |
| GlaxoSmithKline, LLC. | 5 | $130 |
| Indivior Inc. | 4 | $110 |
| Lilly USA, LLC | 5 | $91 |
| Novo Nordisk Inc | 5 | $84 |
| Viatris Specialty LLC | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
Products named: BREZTRI, FARXIGA, AIRSUPRA, CAPLYTA, TRELEGY ELLIPTA, NURTEC ODT, SUBLOCADE, VRAYLAR.
Industry payments across NC — which companies pay providers there.
